Raymond R Schleef

age ~72

from Cardiff by the Sea, CA

Get Report

Also known as:

Phone and address:: 1511 Kings Cross Dr, Cardiff By The Sea, CA 92007
7604368738

Connected to:

Raymond Schleef Phones & Addresses

Name / Title

Company / Classification

Phones & Addresses

Raymond Schleef
Managing

Quinsaat-Schleef LLC
Rental and Investment Properties

635 Fresca St, Solana Beach, CA 92075

Raymond Schleef
Managing

Schleef-Quinsaat LLC
Rental and Investment Properties

635 Fresca St, Solana Beach, CA 92075

Oral Pouch Product Including Soluble Dietary Fibers
view source
US Patent:

8067046, Nov 29, 2011
Filed:

Jun 6, 2008
Appl. No.:

12/155633
Inventors:

Raymond R. Schleef - Germantown MD, US
Seetharama Deevi - Midlothian VA, US
Assignee:

Philip Morris USA Inc. - Richmond VA
International Classification:

B65B 29/02
US Classification:

426 78, 131352, 131111, 131112
Abstract:

Provided is an oral pouch product including a pouch having a plurality of pores. At least one portion of soluble dietary fibers is contained in the pores of the pouch and/or coated thereon. The oral pouch product is filled with a botanical material. The oral pouch product is placed in the mouth to release the soluble dietary fibers directly into the user's mouth.

Diagnostic Assay For Inhibitor Of Tissue-Type And Urokinase-Type Plasminogen Activators
view source
US Patent:

47910682, Dec 13, 1988
Filed:

Jun 22, 1984
Appl. No.:

6/623357
Inventors:

David J. Loskutoff - Solana Beach CA
Raymond R. Schleef - San Diego CA
Assignee:

Scripps Clinic and Research Foundation - La Jolla CA
International Classification:

G01N 33543
US Classification:

436518
Abstract:

A biochemical reagent system and methods for preparing and using same, as well as diagnostics utilizing the reagent system are disclosed. The biochemical reagent system comprises a receptor raised in an animal host to plasminogen activator inhibitor, and indicating means. The receptor binds to a specific plasminogen activator inhibitor that itself binds to tissue-type or urokinase-type plasminogen activators.